IS5809A - Concomitant administration of ACAT and MMP inhibitors for the treatment of fat degeneration - Google Patents
Concomitant administration of ACAT and MMP inhibitors for the treatment of fat degenerationInfo
- Publication number
- IS5809A IS5809A IS5809A IS5809A IS5809A IS 5809 A IS5809 A IS 5809A IS 5809 A IS5809 A IS 5809A IS 5809 A IS5809 A IS 5809A IS 5809 A IS5809 A IS 5809A
- Authority
- IS
- Iceland
- Prior art keywords
- acat
- treatment
- mmp inhibitors
- concomitant administration
- fat degeneration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Quinoline Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9363998P | 1998-07-21 | 1998-07-21 | |
PCT/US1999/013948 WO2000004892A2 (en) | 1998-07-21 | 1999-06-18 | Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
Publications (1)
Publication Number | Publication Date |
---|---|
IS5809A true IS5809A (en) | 2001-01-12 |
Family
ID=22239992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS5809A IS5809A (en) | 1998-07-21 | 2001-01-12 | Concomitant administration of ACAT and MMP inhibitors for the treatment of fat degeneration |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1098662A2 (en) |
JP (1) | JP2002521328A (en) |
KR (1) | KR20010083134A (en) |
CN (1) | CN1310629A (en) |
AP (1) | AP2001002035A0 (en) |
AU (1) | AU4701799A (en) |
BG (1) | BG105162A (en) |
BR (1) | BR9912296A (en) |
CA (1) | CA2335062A1 (en) |
CZ (1) | CZ2001126A3 (en) |
EA (1) | EA200100153A1 (en) |
EE (1) | EE200100046A (en) |
HR (1) | HRP20010055A2 (en) |
HU (1) | HUP0102880A3 (en) |
ID (1) | ID30030A (en) |
IL (1) | IL140982A0 (en) |
IS (1) | IS5809A (en) |
NO (1) | NO20010291L (en) |
OA (1) | OA11584A (en) |
PL (1) | PL346011A1 (en) |
SK (1) | SK502001A3 (en) |
TR (1) | TR200100205T2 (en) |
WO (1) | WO2000004892A2 (en) |
YU (1) | YU3501A (en) |
ZA (1) | ZA200100294B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1414848A (en) * | 1999-11-05 | 2003-04-30 | 沃尼尔·朗伯公司 | Prevention of plaque rupure by ACAT inhibitors |
DOP2000000107A (en) | 1999-12-01 | 2002-09-16 | Agouron Pharmaceutical Inc | COMPOUNDS, COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND LENGTH OF NEURONS |
CA2393825A1 (en) * | 1999-12-17 | 2001-06-21 | Versicor, Inc. | Novel succinate compounds, compositions and methods of use and preparation |
BR0113523A (en) * | 2000-09-01 | 2004-06-29 | Sankyo Co | Pharmaceutical composition, kit, and uses of n- (1-octyl-5-carboxymethyl) -4,6-dimethyl-indolin-7-yl) -2,2-dimethyl-propanamide or a pharmacologically acceptable salt thereof , and a composition |
GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
AU2003229883B2 (en) * | 2002-04-03 | 2009-06-11 | Topotarget Uk Limited | Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors |
WO2004007444A2 (en) * | 2002-07-11 | 2004-01-22 | Vicuron Pharmaceuticals, Inc. | N-hydroxyamide derivatives possessing antibacterial activity |
WO2011092284A1 (en) * | 2010-01-29 | 2011-08-04 | Euroscreen S.A. | Novel amino acid derivatives and their use as gpr43 receptor modulators |
CN104211695B (en) * | 2013-06-04 | 2017-04-12 | 中国医学科学院医药生物技术研究所 | Use of group of carbamyl phenylsulfonyl compounds |
EP3244883A1 (en) * | 2015-01-15 | 2017-11-22 | Biocant - Associação De Transferência De Tecnologia | Treatment of hutchinson-gilford progeria syndrome and diseases related to vascular ageing |
CN106831697B (en) * | 2017-03-15 | 2019-11-05 | 深圳市康道生物有限公司 | The effective extract component of river hazel and its application in prevention and treatment atherosclerosis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366987A (en) * | 1991-08-22 | 1994-11-22 | Warner-Lambert Company | Isoxazolyl-substituted alkyl amide ACAT inhibitors |
US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
JPH11510184A (en) * | 1995-08-04 | 1999-09-07 | ワーナー−ランバート・コンパニー | Use of sulfamic acid derivatives, acylsulfonamides or sulfonyl carbamates for the manufacture of a medicament for reducing lipoprotein levels |
WO1997044315A1 (en) * | 1996-05-17 | 1997-11-27 | Warner-Lambert Company | Biphenylsulfonamide matrix metalloproteinase inhibitors |
EP0931045A1 (en) * | 1996-09-04 | 1999-07-28 | Warner-Lambert Company | Matrix metalloproteinase inhibitors and their therapeutic uses |
-
1999
- 1999-06-18 IL IL14098299A patent/IL140982A0/en unknown
- 1999-06-18 JP JP2000560885A patent/JP2002521328A/en active Pending
- 1999-06-18 OA OA1200100022A patent/OA11584A/en unknown
- 1999-06-18 AP APAP/P/2001/002035A patent/AP2001002035A0/en unknown
- 1999-06-18 BR BR9912296-0A patent/BR9912296A/en not_active IP Right Cessation
- 1999-06-18 CN CN99808958A patent/CN1310629A/en active Pending
- 1999-06-18 EE EEP200100046A patent/EE200100046A/en unknown
- 1999-06-18 KR KR1020017000930A patent/KR20010083134A/en not_active Application Discontinuation
- 1999-06-18 AU AU47017/99A patent/AU4701799A/en not_active Abandoned
- 1999-06-18 ID IDW20010333A patent/ID30030A/en unknown
- 1999-06-18 WO PCT/US1999/013948 patent/WO2000004892A2/en not_active Application Discontinuation
- 1999-06-18 HU HU0102880A patent/HUP0102880A3/en unknown
- 1999-06-18 SK SK50-2001A patent/SK502001A3/en unknown
- 1999-06-18 EP EP99930483A patent/EP1098662A2/en not_active Withdrawn
- 1999-06-18 EA EA200100153A patent/EA200100153A1/en unknown
- 1999-06-18 YU YU3501A patent/YU3501A/en unknown
- 1999-06-18 TR TR2001/00205T patent/TR200100205T2/en unknown
- 1999-06-18 CA CA002335062A patent/CA2335062A1/en not_active Abandoned
- 1999-06-18 PL PL99346011A patent/PL346011A1/en unknown
- 1999-06-18 CZ CZ2001126A patent/CZ2001126A3/en unknown
-
2001
- 2001-01-10 ZA ZA200100294A patent/ZA200100294B/en unknown
- 2001-01-12 IS IS5809A patent/IS5809A/en unknown
- 2001-01-17 BG BG105162A patent/BG105162A/en unknown
- 2001-01-18 NO NO20010291A patent/NO20010291L/en not_active Application Discontinuation
- 2001-01-19 HR HR20010055A patent/HRP20010055A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL140982A0 (en) | 2002-02-10 |
AU4701799A (en) | 2000-02-14 |
PL346011A1 (en) | 2002-01-14 |
SK502001A3 (en) | 2002-06-04 |
NO20010291D0 (en) | 2001-01-18 |
BR9912296A (en) | 2001-04-17 |
EE200100046A (en) | 2002-06-17 |
AP2001002035A0 (en) | 2001-03-31 |
HRP20010055A2 (en) | 2002-04-30 |
HUP0102880A2 (en) | 2002-06-29 |
CZ2001126A3 (en) | 2002-01-16 |
WO2000004892A2 (en) | 2000-02-03 |
ID30030A (en) | 2001-11-01 |
HUP0102880A3 (en) | 2002-11-28 |
NO20010291L (en) | 2001-01-18 |
WO2000004892A3 (en) | 2000-05-18 |
JP2002521328A (en) | 2002-07-16 |
CN1310629A (en) | 2001-08-29 |
CA2335062A1 (en) | 2000-02-03 |
BG105162A (en) | 2001-12-29 |
EA200100153A1 (en) | 2001-08-27 |
KR20010083134A (en) | 2001-08-31 |
YU3501A (en) | 2005-06-10 |
TR200100205T2 (en) | 2001-05-21 |
ZA200100294B (en) | 2002-01-10 |
OA11584A (en) | 2004-07-20 |
EP1098662A2 (en) | 2001-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS5405A (en) | Prostaglandin agonists and their use in the treatment of bone disorders | |
IS2457B (en) | Compositions of drugs (e.g. chlorpromazine and pentamidine) for the treatment of neoplastic disorders | |
IS6560A (en) | Pharmaceutical composition for the treatment of acute, persistent pain and / or nervous system pain and migraine | |
IS5500A (en) | Medicinal preparations for the stimulation and treatment of gastrointestinal disorders and related diseases | |
NO20005190L (en) | Therapeutic angiogenic factors and methods for their use | |
NO994613D0 (en) | Procedures and preparations for the treatment of sleep apnea | |
DK0965578T3 (en) | Hitherto unknown triglycerics and preparations which comprise this | |
NO990296D0 (en) | The HPPD gene and inhibitors | |
NO20011964L (en) | Well treatment fluids and methods for using them | |
DK0927555T3 (en) | Use of cyclooxygenase-2 inhibitors for the treatment and prevention of tumors, tumor-related disorders and cachexia | |
NO993868D0 (en) | 3-piperidyl-4-oxoquinazoline derivatives and medical preparations containing them | |
IS5898A (en) | 5HT1 receptor agonists and metoclopramide for the treatment of migraine | |
IS5233A (en) | Diagnosis of reward deficiency syndrome and its preparations | |
IS5220A (en) | Cyclo-oxygenase-2 selective carprofen for the treatment of pain and inflammation in dogs | |
NO983576D0 (en) | Well treatment fluids and methods | |
IS5809A (en) | Concomitant administration of ACAT and MMP inhibitors for the treatment of fat degeneration | |
NO20002181D0 (en) | Sterilization wrap, its use and method of sterilization | |
DK1041985T3 (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of prophylactic disorders | |
AU2001292019A1 (en) | Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease | |
NO20010464L (en) | Methods and Preparations for the Treatment of Gastroesophageal Reflux Syndrome | |
DK1017388T3 (en) | Pharmaceuticals containing ibuprofen and domperidone for the treatment of migraine | |
NO20012738D0 (en) | Therapeutic products and their use | |
IS6707A (en) | Preparation for the prevention and treatment of cancer | |
NO20013816D0 (en) | Benzamide derivatives and drugs containing them | |
DK1032559T3 (en) | Aminoalkylphenol derivatives for the treatment of depression and memory failure |